{"id":337866,"date":"2025-08-19T13:05:13","date_gmt":"2025-08-19T13:05:13","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-merck\/"},"modified":"2025-08-19T13:05:13","modified_gmt":"2025-08-19T13:05:13","slug":"how-to-buy-merck","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/","title":{"rendered":"How to buy Merck &#038; Co., Inc. (MRK) shares &#8211; Investment in Merck &#038; Co., Inc. (MRK) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334018,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-337866","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Merck & Co., Inc. (MRK) Shares - Investment in Merck & Co., Inc. (MRK) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Merck & Co., Inc. (MRK) Shares - Investment in Merck & Co., Inc. (MRK) Stock"},"description":"Learn how to buy Merck & Co., Inc. (MRK) shares and invest in Merck & Co., Inc. (MRK) stock with our comprehensive analysis of current price, trends, and future outlook.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Merck & Co., Inc. (MRK) shares and invest in Merck & Co., Inc. (MRK) stock with our comprehensive analysis of current price, trends, and future outlook."},"intro":"Thinking about adding a pharmaceutical powerhouse to your portfolio? Merck & Co., Inc. (ticker: MRK) represents one of the most stable yet innovative healthcare investments available today. With a 350-year legacy and blockbuster drugs like Keytruda driving growth, this company offers both defensive characteristics and exciting upside potential. We'll break down everything you need to know about making this investment work for you.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about adding a pharmaceutical powerhouse to your portfolio? Merck & Co., Inc. (ticker: MRK) represents one of the most stable yet innovative healthcare investments available today. With a 350-year legacy and blockbuster drugs like Keytruda driving growth, this company offers both defensive characteristics and exciting upside potential. We'll break down everything you need to know about making this investment work for you."},"body_html":"<h2>\ud83d\udcc8 Merck Stock: Current Price and Critical Dates<\/h2> <p>As of August 19, 2025, Merck & Co., Inc. (MRK) trades at <strong>$84.22<\/strong> on the NYSE. Mark your calendar: <strong>October 30, 2025<\/strong> is absolutely critical. That's when Merck releases its Q3 earnings report, and historically, these announcements create significant price movements.<\/p> <h3>How Earnings Reports Move MRK Stock<\/h3> <p>Based on recent patterns, Merck's earnings releases typically cause 3-8% price swings within 48 hours. The company's most recent report on July 29, 2025, showed impressive results with worldwide sales of $15.8 billion and non-GAAP EPS of $2.13 beating estimates by 3.26% (<a href=\"https:\/\/www.merck.com\/news\/merck-co-inc-rahway-n-j-usa-announces-second-quarter-2025-financial-results\/\">Q2 2025 Results<\/a>).<\/p> <p>Historical data reveals that positive earnings surprises typically boost the stock by 4-6% in the following week, while misses cause temporary dips of 3-5% before recovery. Given Merck's track record of beating estimates, the October report could provide a nice catalyst.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey (March-August 2025)<\/h2> <p>Merck shares have experienced quite the rollercoaster over the past six months, showing both resilience and volatility:<\/p> <p><strong>March 2025<\/strong>: $97.37 (six-month high reached on March 7th)<br\/> <strong>April 2025<\/strong>: $85-90 range (consolidation phase)<br\/> <strong>May 2025<\/strong>: $73.31 (six-month low hit on May 15th - tariff concerns)<br\/> <strong>June 2025<\/strong>: $79.16 (recovery begins)<br\/> <strong>July 2025<\/strong>: $78.12 (summer stability)<br\/> <strong>August 2025<\/strong>: $84.21 (current recovery momentum)<\/p> <p>This represents a <strong>14.87% recovery<\/strong> from the May lows, demonstrating the stock's ability to bounce back from setbacks (<a href=\"https:\/\/www.barchart.com\/stocks\/quotes\/mrk\/performance\">Performance Data<\/a>). The trading range of approximately $24 between highs and lows shows why timing matters with pharmaceutical stocks.<\/p> <h3>Why the Volatility?<\/h3> <ul> <li><strong>Tariff concerns<\/strong> in May caused the sharp drop<\/li> <li><strong>Keytruda patent cliff<\/strong> anxiety created selling pressure<\/li> <li><strong>Strong Q2 earnings<\/strong> in July provided support<\/li> <li><strong>New drug approvals<\/strong> throughout 2025 built confidence<\/li> <\/ul> <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <h3>2025 Year-End: $85-95 Range \u2192 BUY<\/h3> <p>Analysts project Merck could finish 2025 between $85-95, representing potential upside of 1-13% from current levels. The conservative estimate of $77.08 seems overly pessimistic given recent momentum (<a href=\"https:\/\/tradersunion.com\/currencies\/forecast\/mrk-usd\/\">2025 Forecast<\/a>).<\/p> <h3>2026 Projection: $89-92<\/h3> <p>Mid-year targets around $89.63 with year-end reaching $92.35 appear reasonable based on pipeline developments and market expansion.<\/p> <h3>2028 Outlook: $101-104<\/h3> <p>By 2028, Merck's diversification efforts should bear fruit, pushing the stock above $100 for the first time in years.<\/p> <h3>2030 Vision: $117-187<\/h3> <p>Long-term forecasts vary widely from conservative $117 to optimistic $187, reflecting uncertainty around patent expirations and new drug success (<a href=\"https:\/\/stockscan.io\/stocks\/MRK\/forecast\">Long-term Projections<\/a>).<\/p> <p><strong>Verdict<\/strong>: STRONG BUY for long-term investors. Current valuation at 9x forward P\/E represents significant discount to historical averages.<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><strong>Patent Cliff Anxiety<\/strong>: Keytruda's approaching patent expiration creates uncertainty despite mitigation efforts (<a href=\"https:\/\/monexa.ai\/blog\/merck-s-strategy-navigating-keytruda-cliff-with-pi-MRK-2025-06-05\">Patent Strategy<\/a>)<\/li> <li><strong>Regulatory Hurdles<\/strong>: FDA approval processes remain rigorous and unpredictable<\/li> <li><strong>Tariff Exposure<\/strong>: $200 million in anticipated tariff costs for 2025 could impact margins<\/li> <li><strong>Competition Intensification<\/strong>: Rivals developing similar oncology treatments<\/li> <\/ul> <h3>Green Lights for 2025<\/h3> <ul> <li><strong>Pipeline Powerhouse<\/strong>: 20 potential blockbuster drugs in development representing $50+ billion opportunity<\/li> <li><strong>Recent FDA Wins<\/strong>: KEYTRUDA expansion, ENFLONSIA approval, WELIREG pediatric indication<\/li> <li><strong>Strategic Acquisition<\/strong>: $10 billion Verona Pharma deal adding Ohtuvayre to respiratory portfolio<\/li> <li><strong>WINREVAIR Success<\/strong>: $336 million Q2 sales with cumulative over $1 billion<\/li> <li><strong>Dividend Strength<\/strong>: 3.8% yield with sustainable 49% payout ratio<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start small<\/strong> - Use dollar-cost averaging with weekly or monthly purchases<\/li> <li><strong>Set earnings alerts<\/strong> - Monitor around October 30 for potential entry points<\/li> <li><strong>Think long-term<\/strong> - Pharmaceutical stocks require patience for pipeline to mature<\/li> <li><strong>Diversify properly<\/strong> - Keep MRK at 5-10% of total portfolio maximum<\/li> <\/ol> <p>Humorous take: \"Trading MRK is like waiting for clinical trial results - sometimes you get breakthrough therapy designation, sometimes you get side effects. Either way, you'll need strong stomach medicine!\"<\/p> <h2>\u2705 How to Buy Merck & Co., Inc. (MRK) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NYSE access and reasonable fees<\/td><\/tr> <tr><td>2<\/td><td>Complete account funding<\/td><td>Start with amount you're comfortable risking<\/td><\/tr> <tr><td>3<\/td><td>Search \"MRK\" ticker<\/td><td>Use the exact symbol, not just \"Merck\"<\/td><\/tr> <tr><td>4<\/td><td>Select order type<\/td><td>Limit orders prevent overpaying during volatility<\/td><\/tr> <tr><td>5<\/td><td>Review and confirm<\/td><td>Check commission rates before finalizing<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2> <p>For those starting their investment journey, Pocket Option offers several advantages that make entering the stock market less intimidating:<\/p> <ul> <li><strong>Minimum deposit just $5<\/strong> - Perfect for testing strategies without significant risk<\/li> <li><strong>1-minute KYC process<\/strong> - Upload any government ID and start trading immediately<\/li> <li><strong>100+ withdrawal methods<\/strong> - Flexibility with crypto, e-wallets, and traditional banking<\/li> <li><strong>Fractional shares available<\/strong> - Buy pieces of expensive stocks like MRK with small amounts<\/li> <\/ul> <p>The platform's user-friendly interface makes navigating complex pharmaceutical stocks much simpler for beginners who want exposure to healthcare sector growth.<\/p> <h2>\ud83c\udf0d Merck in 2025: Healthcare's Innovation Engine<\/h2> <p>Merck stands as a pharmaceutical titan with approaching $61 billion in annual revenue and market valuation consistently above $330 billion (<a href=\"https:\/\/dcfmodeling.com\/blogs\/history\/mrk-history-mission-ownership\">Company Metrics<\/a>). Beyond its famous cancer drugs, the company leads in vaccine development, animal health, and diverse therapeutic areas.<\/p> <p>The company's pipeline has nearly tripled since 2021, with 20 potential blockbuster drugs representing over $50 billion in future revenue potential (<a href=\"https:\/\/fortune.com\/well\/2025\/02\/04\/merck-touts-new-blockbuster-drugs-50-billion-potential\/\">Pipeline Value<\/a>). Recent successes include WINREVAIR achieving $336 million in Q2 sales and the $10 billion acquisition of Verona Pharma adding respiratory drug Ohtuvayre.<\/p> <p><strong>Interesting Fact<\/strong>: Merck sold the first commercially used smallpox vaccine in the United States back in 1898, and today they're still making vaccine history with recent FDA approval of ENFLONSIA for RSV prevention in infants!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Merck Stock: Current Price and Critical Dates<\/h2>\n<p>As of August 19, 2025, Merck &#038; Co., Inc. (MRK) trades at <strong>$84.22<\/strong> on the NYSE. Mark your calendar: <strong>October 30, 2025<\/strong> is absolutely critical. That&#8217;s when Merck releases its Q3 earnings report, and historically, these announcements create significant price movements.<\/p>\n<h3>How Earnings Reports Move MRK Stock<\/h3>\n<p>Based on recent patterns, Merck&#8217;s earnings releases typically cause 3-8% price swings within 48 hours. The company&#8217;s most recent report on July 29, 2025, showed impressive results with worldwide sales of $15.8 billion and non-GAAP EPS of $2.13 beating estimates by 3.26% (<a href=\"https:\/\/www.merck.com\/news\/merck-co-inc-rahway-n-j-usa-announces-second-quarter-2025-financial-results\/\">Q2 2025 Results<\/a>).<\/p>\n<p>Historical data reveals that positive earnings surprises typically boost the stock by 4-6% in the following week, while misses cause temporary dips of 3-5% before recovery. Given Merck&#8217;s track record of beating estimates, the October report could provide a nice catalyst.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey (March-August 2025)<\/h2>\n<p>Merck shares have experienced quite the rollercoaster over the past six months, showing both resilience and volatility:<\/p>\n<p><strong>March 2025<\/strong>: $97.37 (six-month high reached on March 7th)<br \/> <strong>April 2025<\/strong>: $85-90 range (consolidation phase)<br \/> <strong>May 2025<\/strong>: $73.31 (six-month low hit on May 15th &#8211; tariff concerns)<br \/> <strong>June 2025<\/strong>: $79.16 (recovery begins)<br \/> <strong>July 2025<\/strong>: $78.12 (summer stability)<br \/> <strong>August 2025<\/strong>: $84.21 (current recovery momentum)<\/p>\n<p>This represents a <strong>14.87% recovery<\/strong> from the May lows, demonstrating the stock&#8217;s ability to bounce back from setbacks (<a href=\"https:\/\/www.barchart.com\/stocks\/quotes\/mrk\/performance\">Performance Data<\/a>). The trading range of approximately $24 between highs and lows shows why timing matters with pharmaceutical stocks.<\/p>\n<h3>Why the Volatility?<\/h3>\n<ul>\n<li><strong>Tariff concerns<\/strong> in May caused the sharp drop<\/li>\n<li><strong>Keytruda patent cliff<\/strong> anxiety created selling pressure<\/li>\n<li><strong>Strong Q2 earnings<\/strong> in July provided support<\/li>\n<li><strong>New drug approvals<\/strong> throughout 2025 built confidence<\/li>\n<\/ul>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<h3>2025 Year-End: $85-95 Range \u2192 BUY<\/h3>\n<p>Analysts project Merck could finish 2025 between $85-95, representing potential upside of 1-13% from current levels. The conservative estimate of $77.08 seems overly pessimistic given recent momentum (<a href=\"https:\/\/tradersunion.com\/currencies\/forecast\/mrk-usd\/\">2025 Forecast<\/a>).<\/p>\n<h3>2026 Projection: $89-92<\/h3>\n<p>Mid-year targets around $89.63 with year-end reaching $92.35 appear reasonable based on pipeline developments and market expansion.<\/p>\n<h3>2028 Outlook: $101-104<\/h3>\n<p>By 2028, Merck&#8217;s diversification efforts should bear fruit, pushing the stock above $100 for the first time in years.<\/p>\n<h3>2030 Vision: $117-187<\/h3>\n<p>Long-term forecasts vary widely from conservative $117 to optimistic $187, reflecting uncertainty around patent expirations and new drug success (<a href=\"https:\/\/stockscan.io\/stocks\/MRK\/forecast\">Long-term Projections<\/a>).<\/p>\n<p><strong>Verdict<\/strong>: STRONG BUY for long-term investors. Current valuation at 9x forward P\/E represents significant discount to historical averages.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><strong>Patent Cliff Anxiety<\/strong>: Keytruda&#8217;s approaching patent expiration creates uncertainty despite mitigation efforts (<a href=\"https:\/\/monexa.ai\/blog\/merck-s-strategy-navigating-keytruda-cliff-with-pi-MRK-2025-06-05\">Patent Strategy<\/a>)<\/li>\n<li><strong>Regulatory Hurdles<\/strong>: FDA approval processes remain rigorous and unpredictable<\/li>\n<li><strong>Tariff Exposure<\/strong>: $200 million in anticipated tariff costs for 2025 could impact margins<\/li>\n<li><strong>Competition Intensification<\/strong>: Rivals developing similar oncology treatments<\/li>\n<\/ul>\n<h3>Green Lights for 2025<\/h3>\n<ul>\n<li><strong>Pipeline Powerhouse<\/strong>: 20 potential blockbuster drugs in development representing $50+ billion opportunity<\/li>\n<li><strong>Recent FDA Wins<\/strong>: KEYTRUDA expansion, ENFLONSIA approval, WELIREG pediatric indication<\/li>\n<li><strong>Strategic Acquisition<\/strong>: $10 billion Verona Pharma deal adding Ohtuvayre to respiratory portfolio<\/li>\n<li><strong>WINREVAIR Success<\/strong>: $336 million Q2 sales with cumulative over $1 billion<\/li>\n<li><strong>Dividend Strength<\/strong>: 3.8% yield with sustainable 49% payout ratio<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start small<\/strong> &#8211; Use dollar-cost averaging with weekly or monthly purchases<\/li>\n<li><strong>Set earnings alerts<\/strong> &#8211; Monitor around October 30 for potential entry points<\/li>\n<li><strong>Think long-term<\/strong> &#8211; Pharmaceutical stocks require patience for pipeline to mature<\/li>\n<li><strong>Diversify properly<\/strong> &#8211; Keep MRK at 5-10% of total portfolio maximum<\/li>\n<\/ol>\n<p>Humorous take: &#8220;Trading MRK is like waiting for clinical trial results &#8211; sometimes you get breakthrough therapy designation, sometimes you get side effects. Either way, you&#8217;ll need strong stomach medicine!&#8221;<\/p>\n<h2>\u2705 How to Buy Merck &#038; Co., Inc. (MRK) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NYSE access and reasonable fees<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete account funding<\/td>\n<td>Start with amount you&#8217;re comfortable risking<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Search &#8220;MRK&#8221; ticker<\/td>\n<td>Use the exact symbol, not just &#8220;Merck&#8221;<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Select order type<\/td>\n<td>Limit orders prevent overpaying during volatility<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Review and confirm<\/td>\n<td>Check commission rates before finalizing<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2>\n<p>For those starting their investment journey, Pocket Option offers several advantages that make entering the stock market less intimidating:<\/p>\n<ul>\n<li><strong>Minimum deposit just $5<\/strong> &#8211; Perfect for testing strategies without significant risk<\/li>\n<li><strong>1-minute KYC process<\/strong> &#8211; Upload any government ID and start trading immediately<\/li>\n<li><strong>100+ withdrawal methods<\/strong> &#8211; Flexibility with crypto, e-wallets, and traditional banking<\/li>\n<li><strong>Fractional shares available<\/strong> &#8211; Buy pieces of expensive stocks like MRK with small amounts<\/li>\n<\/ul>\n<p>The platform&#8217;s user-friendly interface makes navigating complex pharmaceutical stocks much simpler for beginners who want exposure to healthcare sector growth.<\/p>\n<h2>\ud83c\udf0d Merck in 2025: Healthcare&#8217;s Innovation Engine<\/h2>\n<p>Merck stands as a pharmaceutical titan with approaching $61 billion in annual revenue and market valuation consistently above $330 billion (<a href=\"https:\/\/dcfmodeling.com\/blogs\/history\/mrk-history-mission-ownership\">Company Metrics<\/a>). Beyond its famous cancer drugs, the company leads in vaccine development, animal health, and diverse therapeutic areas.<\/p>\n<p>The company&#8217;s pipeline has nearly tripled since 2021, with 20 potential blockbuster drugs representing over $50 billion in future revenue potential (<a href=\"https:\/\/fortune.com\/well\/2025\/02\/04\/merck-touts-new-blockbuster-drugs-50-billion-potential\/\">Pipeline Value<\/a>). Recent successes include WINREVAIR achieving $336 million in Q2 sales and the $10 billion acquisition of Verona Pharma adding respiratory drug Ohtuvayre.<\/p>\n<p><strong>Interesting Fact<\/strong>: Merck sold the first commercially used smallpox vaccine in the United States back in 1898, and today they&#8217;re still making vaccine history with recent FDA approval of ENFLONSIA for RSV prevention in infants!<\/p>\n"},"faq":[{"question":"What is Merck's dividend yield and how often do they pay?","answer":"Merck currently offers a 3.8% dividend yield with quarterly payments of $0.81 per share. The company has maintained dividend payments for decades."},{"question":"When does Keytruda lose patent protection?","answer":"Keytruda faces patent expiration around 2028, but Merck has developed subcutaneous formulations and other strategies to extend its commercial life."},{"question":"Is Merck a good long-term investment despite patent concerns?","answer":"Yes, the company's diversified pipeline and recent acquisitions position it well for growth beyond Keytruda's patent cliff."},{"question":"What percentage of revenue comes from Keytruda?","answer":"Keytruda represents approximately 40% of total revenue, but this percentage is decreasing as other products grow."},{"question":"How does Merck's valuation compare to competitors?","answer":"At 9x forward P\/E, Merck trades at a significant discount to pharmaceutical industry averages, making it attractive value."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What is Merck's dividend yield and how often do they pay?","answer":"Merck currently offers a 3.8% dividend yield with quarterly payments of $0.81 per share. The company has maintained dividend payments for decades."},{"question":"When does Keytruda lose patent protection?","answer":"Keytruda faces patent expiration around 2028, but Merck has developed subcutaneous formulations and other strategies to extend its commercial life."},{"question":"Is Merck a good long-term investment despite patent concerns?","answer":"Yes, the company's diversified pipeline and recent acquisitions position it well for growth beyond Keytruda's patent cliff."},{"question":"What percentage of revenue comes from Keytruda?","answer":"Keytruda represents approximately 40% of total revenue, but this percentage is decreasing as other products grow."},{"question":"How does Merck's valuation compare to competitors?","answer":"At 9x forward P\/E, Merck trades at a significant discount to pharmaceutical industry averages, making it attractive value."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Merck &amp; Co., Inc. (MRK) shares - Investment in Merck &amp; Co., Inc. (MRK) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Merck &amp; Co., Inc. (MRK) shares - Investment in Merck &amp; Co., Inc. (MRK) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-19T13:05:13+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Merck &#038; Co., Inc. (MRK) shares &#8211; Investment in Merck &#038; Co., Inc. (MRK) stock\",\"datePublished\":\"2025-08-19T13:05:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/\"},\"wordCount\":17,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/\",\"name\":\"How to buy Merck & Co., Inc. (MRK) shares - Investment in Merck & Co., Inc. (MRK) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"datePublished\":\"2025-08-19T13:05:13+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Merck &#038; Co., Inc. (MRK) shares &#8211; Investment in Merck &#038; Co., Inc. (MRK) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Merck & Co., Inc. (MRK) shares - Investment in Merck & Co., Inc. (MRK) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Merck & Co., Inc. (MRK) shares - Investment in Merck & Co., Inc. (MRK) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-19T13:05:13+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Merck &#038; Co., Inc. (MRK) shares &#8211; Investment in Merck &#038; Co., Inc. (MRK) stock","datePublished":"2025-08-19T13:05:13+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/"},"wordCount":17,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/","name":"How to buy Merck & Co., Inc. (MRK) shares - Investment in Merck & Co., Inc. (MRK) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","datePublished":"2025-08-19T13:05:13+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-merck\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Merck &#038; Co., Inc. (MRK) shares &#8211; Investment in Merck &#038; Co., Inc. (MRK) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":337937,"slug":"how-to-buy-merck","post_title":"Comment acheter des actions Merck & Co., Inc. (MRK) - Investir dans les actions Merck & Co., Inc. (MRK)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-merck\/"},"it_IT":{"locale":"it_IT","id":337930,"slug":"how-to-buy-merck","post_title":"Come acquistare azioni Merck & Co., Inc. (MRK) - Investire in azioni Merck & Co., Inc. (MRK)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-merck\/"},"pl_PL":{"locale":"pl_PL","id":337934,"slug":"how-to-buy-merck","post_title":"Jak kupi\u0107 akcje Merck & Co., Inc. (MRK) - Inwestycja w akcje Merck & Co., Inc. (MRK)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-merck\/"},"es_ES":{"locale":"es_ES","id":337933,"slug":"how-to-buy-merck","post_title":"C\u00f3mo comprar acciones de Merck & Co., Inc. (MRK) - Inversi\u00f3n en acciones de Merck & Co., Inc. (MRK)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-merck\/"},"th_TH":{"locale":"th_TH","id":337931,"slug":"how-to-buy-merck","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Merck & Co., Inc. (MRK) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Merck & Co., Inc. (MRK)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-merck\/"},"tr_TR":{"locale":"tr_TR","id":337932,"slug":"how-to-buy-merck","post_title":"Merck & Co., Inc. (MRK) Hisseleri Nas\u0131l Al\u0131n\u0131r - Merck & Co., Inc. (MRK) Hisse Senedine Yat\u0131r\u0131m","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merck\/"},"vt_VT":{"locale":"vt_VT","id":337935,"slug":"how-to-buy-merck","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Merck & Co., Inc. (MRK) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Merck & Co., Inc. (MRK)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-merck\/"},"pt_AA":{"locale":"pt_AA","id":337936,"slug":"how-to-buy-merck","post_title":"Como comprar a\u00e7\u00f5es da Merck & Co., Inc. (MRK) - Investimento em a\u00e7\u00f5es da Merck & Co., Inc. (MRK)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-merck\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/337866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=337866"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/337866\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334018"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=337866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=337866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=337866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}